Olmin20-AH Tablet
Marketer
Eris Lifesciences Ltd
Salt Composition
Olmesartan Medoxomil (20mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olmin20-AH Tablet
Combiflex-20 tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, thereby mitigating the risk of stroke and heart attack. Combiflex-20 may be taken with or without food; dosage is individualized based on response and condition. Consistent daily timing is recommended. Continue this medication as directed by your physician. Due to its diuretic component, increased urination is expected; avoid administration within four hours of bedtime. Regular use is crucial for optimal effect, even during asymptomatic periods. Discontinuing treatment elevates stroke and heart attack risk. Common side effects include edema (ankle swelling), headache, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your physician. Maintain adequate hydration to alleviate potential muscle weakness, xerostomia (dry mouth), and excessive thirst. Disclose pre-existing liver or kidney conditions, pregnancy, or breastfeeding status to your doctor before initiating treatment. Inform your physician of all other medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, electrolyte levels, and blood glucose is vital to ensure treatment efficacy.
Primary Ingredients of Olmin20-AH Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Olmin20-AH Tablet
Elevated blood pressure
Major Benefits of Olmin20-AH Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Olmin20-AH Tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Olmin20-AH Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olmin20-AH Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Olmin20-AH Tablet whole; do not break, crush, or chew it. While consumption with or without food is acceptable, consistent timing is recommended.
How Olmin20-AH Tablet works:
Olmesartan Medoxomil, amlodipine, and hydrochlorothiazide are combined in Olmin20-AH tablets. Olmesartan Medoxomil, an angiotensin receptor blocker (ARB), and amlodipine, a calcium channel blocker (CCB), both act to dilate blood vessels, resulting in reduced blood pressure. Hydrochlorothiazide, a diuretic, contributes by eliminating excess fluid and electrolytes via urination, and also gradually promotes vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Olmin20-AH Tablet and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Olmin20-AH tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is discouraged. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Olmin20-AH tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Olmin20-AH Tablet side effects. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmin20-AH Tablets, potentially requiring dosage modification under medical supervision. Olmin20-AH Tablets are contraindicated in individuals with severe renal dysfunction.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Olmin20-AH Tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Olmin20-AH Tablet :
Should you forget to take your Olmin20-AH Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Olmin20-AH Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



